A human beta-cell line for transplantation therapy to control type 1 diabetes.
Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li SA, Chen Y, Miki A, Tanaka K, Nakaji S, Takei K, Gutierrez AS, Rivas-Carrillo JD, Navarro-Alvarez N, Jun HS, Westerman KA, Noguchi H, Lakey JR, Leboulch P, Tanaka N, Yoon JW.
Narushima M, et al. Among authors: tanaka k, tanaka n, tanaka y.
Nat Biotechnol. 2005 Oct;23(10):1274-82. doi: 10.1038/nbt1145. Epub 2005 Sep 25.
Nat Biotechnol. 2005.
PMID: 16186810